Levalox (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition prevents bacterial cells from dividing and repairing their DNA, leading to bacterial death and resolution of the infection.

The dosage of Levalox is determined by the prescribing clinician based on the specific infection, patient age, weight, renal function, and local resistance patterns. Patients should follow the prescriber’s instructions and the product label.

Safety of levofloxacin in pregnancy and lactation has not been definitively established. It is generally avoided unless the potential benefit outweighs the potential risk to the fetus or infant, and only under medical supervision.

To request Levalox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levalox (levofloxacin) offers a broad spectrum of activity against Gram‑positive and Gram‑negative bacteria, with once‑daily dosing for many indications. Compared with older fluoroquinolones, it often provides higher potency against respiratory pathogens and a more convenient dosing schedule, though safety considerations remain similar across the class.

Levalox should be stored at room temperature, below 25 °C, in its original container, protected from moisture and direct sunlight. Do not store in a bathroom or near heat sources to maintain product stability.

Levalox is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminum or magnesium, as these may reduce absorption.

Serious risks include tendon rupture, especially in older adults or those on corticosteroids; QT interval prolongation leading to cardiac arrhythmias; severe hypersensitivity reactions such as Stevens‑Johnson syndrome; Clostridioides difficile‑associated colitis; and peripheral neuropathy.

Levalox is contraindicated in patients with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and individuals taking medications that significantly prolong the QT interval without appropriate monitoring.